This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Grima DT, Thompson MF, Sauriol L.Modelling cost effectiveness of insulin glargine for the treatment of type 1 and type 2 diabetes in Canada. PharmacoEconomics 25: 253-266, No. 3, 2007
About this article
Cite this article
ICERs favour long-term insulin glargine for diabetes. Pharmacoecon. Outcomes News 524, 7 (2007). https://doi.org/10.2165/00151234-200705240-00010
- Insulin Glargine
- Emergency Room Visit
- Baseline HbA1c
- United Kingdom Prospective Diabetes Study
- Canadian Dollar